ᱱᱤᱢᱩᱥᱞᱟᱭᱰ
 | |
| ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ | |
|---|---|
| ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ | International Drug Names |
| ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ ᱴᱷᱟᱶ | By mouth, rectal, topical |
| ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ | |
| ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ | |
| ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ |
|
| ᱯᱷᱟᱨᱢᱟᱠᱳᱠᱟᱭᱱᱮᱴᱤᱠ ᱰᱮᱴᱟ | |
| ᱯᱨᱳᱴᱤᱱ ᱛᱚᱱᱚᱞ | >97.5% |
| ᱢᱮᱴᱟᱵᱳᱞᱤᱡᱚᱢ | Hepatic |
| ᱵᱟᱹᱜᱤ ᱟᱫᱷᱟ-ᱡᱤᱭᱚᱱ | 1.8–4.7h |
| ᱨᱟᱪᱟᱥᱮᱫ | Renal (50%), fecal (29%) |
| ᱩᱯᱨᱩᱢᱤᱭᱟᱹ | |
| |
| ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ | |
| ᱯᱟᱵᱽᱠᱮᱢ ᱥᱤ.ᱟᱭ.ᱰᱤ | |
| ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮᱭᱤᱪ.ᱮ.ᱟᱨ/ᱵᱤ.ᱯᱤ.ᱮᱥ | |
| ᱰᱨᱟᱜᱵᱮᱸᱠ | |
| ᱠᱮᱢᱥᱯᱟᱭᱰᱟᱨ | |
| ᱭᱩ.ᱮᱱ.ᱟᱭ.ᱟᱭ | |
| ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ | |
| ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱵᱤ.ᱟᱭ | |
| ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱮᱢ.ᱵᱤ.ᱮᱞ | |
| ECHA InfoCard | 100.052.194  |
| Chemical and physical data | |
| ᱯᱷᱚᱨᱢᱩᱞᱟ | C13H12N2O5S |
| ᱢᱤᱞᱟᱨ ᱢᱟᱥ | Error in {{val}}: parameter 1 is not a valid number. g·mol−1 |
| ᱛᱷᱨᱤᱰᱤ ᱢᱚᱰᱮᱞ (ᱡᱮ.ᱮᱥ.ᱢᱳᱞ) | |
| |
| |
ᱪᱷᱟᱸᱪ:Cross (what is this?) (verify) | |
ᱱᱤᱢᱩᱥᱞᱟᱭᱰ ᱫᱚ ᱵᱟᱹᱲᱛᱤ ᱦᱟᱹᱥᱩ ᱠᱚᱣᱟ ᱩᱱ ᱚᱠᱛᱮ ᱱᱚᱶᱟ ᱨᱟᱱ ᱠᱚ ᱡᱚᱢᱟ ᱟᱨ ᱱᱚᱶᱟ ᱫᱚ ᱨᱩᱣᱟᱹᱜ ᱠᱚ ᱠᱚᱢ ᱟᱱᱟᱜ ᱜᱩᱱ ᱥᱟᱶ ᱢᱤᱫ ᱱᱟᱹᱱᱥᱴᱮᱨᱟᱹᱭᱤᱰᱚᱞ ᱮᱱᱴᱤ-ᱤᱱᱯᱷᱞᱮᱢᱮᱴᱚᱨᱤ ᱰᱨᱚᱜᱽ (NSAID) ᱠᱟᱱᱟ ᱾ ᱱᱚᱶᱟ ᱨᱮᱱᱟᱜ ᱯᱩᱨᱟᱹ ᱵᱟᱰᱟᱭ ᱚᱪᱚ ᱫᱚ ᱟᱹᱰᱤ ᱡᱚᱨ ᱜᱮ ᱦᱟᱹᱥᱩ, ᱢᱟᱨᱮᱭᱟᱜ ᱟᱹᱥᱴᱤᱭᱳᱟᱨᱛᱷᱨᱟᱭᱴᱤᱥ ᱨᱮᱱᱟᱜ ᱨᱚᱜᱽ ᱩᱨᱩᱢ ᱴᱨᱤᱴ ᱟᱨ ᱑᱒ ᱵᱚᱭᱚᱥ ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱩᱢᱮᱨ ᱨᱮᱱ ᱴᱤᱱᱮᱡᱽ ᱠᱚᱣᱟᱜ ᱟᱨ ᱚᱱᱟ ᱠᱷᱚᱱ ᱢᱟᱨᱟᱝ ᱦᱚᱲ ᱨᱮ ᱮᱛᱚᱦᱚᱵ ᱰᱤᱥᱢᱮᱱᱳᱨᱤᱭᱟ ᱨᱮᱱᱟᱜ ᱴᱨᱤᱴ ᱢᱮᱱᱟᱜ-ᱟ ᱾
ᱥᱟᱭᱤᱰ ᱤᱯᱷᱮᱠᱴ ᱨᱮ ᱭᱟᱠᱨᱤᱛ ᱨᱮᱱᱟᱜ ᱠᱚᱥᱴᱚ ᱦᱚᱸ ᱥᱮᱞᱮᱫ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ ᱱᱚᱶᱟ ᱨᱮ ᱮᱠᱥᱚᱱ ᱦᱟᱛᱟᱣ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫ ᱵᱟᱦᱩᱭ ᱠᱨᱤᱭᱟᱥᱤᱞ ᱢᱳᱰ ᱢᱮᱱᱟᱜ-ᱟ ᱟᱨ ᱱᱚᱶᱟ ᱨᱮ ᱮᱠᱥᱚᱱ ᱦᱟᱛᱟᱣ ᱨᱮᱱᱟᱜ ᱡᱚᱨ ᱮᱛᱚᱦᱚᱵ ᱨᱮᱱᱟᱜ ᱵᱤᱥᱮᱥ ᱢᱮᱱᱟᱜ-ᱥ ᱾ ᱱᱚᱶᱟ ᱯᱨᱳᱥᱴᱟᱜᱽᱞᱮᱱᱰᱤᱥ (ᱦᱟᱹᱥᱩ ᱥᱟᱶ ᱡᱚᱲᱟᱣ ᱟᱠᱟᱱ ᱢᱤᱫ ᱠᱮᱢᱤᱠᱟᱞ) ᱨᱮᱱᱟᱜ ᱟᱨᱡᱟᱣ ᱚᱣᱨᱤᱫᱷ ᱠᱟᱛᱮ ᱠᱟᱹᱢᱤ ᱮᱫ ᱟᱭ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱦᱟᱹᱥᱩ ᱟᱨ ᱞᱟᱦᱨᱟᱣ ᱠᱷᱚᱱ ᱡᱤᱨᱟᱹᱣ ᱚᱪᱚ ᱮᱫ ᱟᱭ ᱾
ᱢᱮᱰᱤᱠᱮᱥᱚᱱ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]
ᱢᱮᱰᱤᱠᱟᱞ ᱵᱮᱵᱷᱟᱨ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]
ᱱᱤᱢᱥᱞᱟᱭᱰ ᱨᱟᱱ ᱭᱩᱱᱟᱭᱴᱮᱰ ᱥᱴᱮᱴ ᱨᱮ ᱵᱮᱵᱚᱥᱛᱟ ᱵᱟᱹᱱᱩᱜ ᱟᱠᱟᱫ-ᱟ, ᱦᱟᱹᱥᱩ ᱠᱷᱚᱱ ᱠᱚᱢᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱭᱩᱱᱟᱭᱴᱮᱰ ᱥᱴᱮᱴ ᱪᱷᱟᱲᱟ ᱥᱟᱱᱟᱢ ᱫᱤᱥᱚᱢ ᱨᱮᱜᱮ ᱠᱚ ᱵᱮᱵᱷᱟᱨ ᱮᱫ ᱜᱮᱭᱟ ᱾[᱑] ᱱᱚᱶᱟ ᱱᱤᱢᱥᱞᱟᱭᱰ ᱨᱟᱱ ᱫᱚ ᱡᱟᱦᱟᱸᱭ ᱠᱚ ᱯᱤᱨᱤᱭᱟᱰ ᱯᱮᱭᱱ ᱦᱟᱹᱥᱩ ᱦᱩᱭ ᱟᱠᱚ ᱠᱟᱱᱟ ᱩᱱᱠᱩ ᱱᱚᱶᱟ ᱨᱟᱱ ᱠᱚ ᱡᱚᱢ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ ᱱᱤᱢᱥᱞᱟᱭᱰ ᱫᱚ ᱞᱳᱝ ᱴᱚᱨᱢ ᱟᱱᱟᱜ ᱫᱚ ᱵᱟᱝ ᱠᱟᱱᱟ ᱱᱚᱶᱟ ᱫᱚ ᱠᱨᱚᱱᱤᱠ ᱠᱚᱱᱰᱤᱥᱚᱱ ᱡᱮᱞᱮᱠᱟ ᱟᱨᱛᱷᱨᱟᱭᱴᱤᱥ ᱾
ᱥᱟᱹᱠᱷᱭᱟᱹᱛ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]
- ↑ "Nimesulide". livertox.nih.gov. Archived from the original on 23 December 2017. Retrieved 22 December 2017.